Skin DiseasesNCT01969422
Online Question-answering and Conventional Consultation With a Dermatologist
An observational study of Skin Diseases, run by University of Zurich at 1 site in Switzerland.
Trial summary
Comparison of online question-answering system and conventional consultation for dermatological questions: same diagnosis? same information, which had been collected? same recommendations about treatment? what were the relevant differences of the two? Read more about this study
- Who is it for?
- Ages 1 year and older
- Conditions the study is for
- Skin Diseases
- What is being tested?
- observation
- Type of treatment
- Surgery or procedure
- How many people
- 100 participants
- Where
- 1 siteSwitzerland
- Study dates
- Nov 2013to Sep 2014
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 year and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: persons with a question on skin disease
Who may be able to join
- a conventional dermatological consultation after a question in the online question-answering system.
Who cannot join
- -power of veto after information of patient
Trial locations and contacts
1 site in 1 country.
Switzerland1 site
University Hospital Zurich, Department of Dermatology
Zurich, Canton of Zurich, 8091
About this study
Comparison of online question-answering system and conventional consultation for dermatological questions:
- same diagnosis?
- same information, which had been collected?
- same recommendations about treatment?
- what were the relevant differences of the two?
Read the detailed description
mainly, ICD codes and dermatological diagnosis codes according to the AAD will be used.
- Conditions
- Skin Diseases
- Being tested
- observation
- Medical subject headings
- Skin Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
observationProcedure or surgery
intervention is the contact with online question answering serice ad subseudd
| Study group | Role | What they receive |
|---|---|---|
| observation group | observation Receives: Procedure: observation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Correlation of online and clinical diagnosis by Spearman's Rho
Measured: physical consultation date
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Oct 2013 (estimated)
- Study startNov 2013
- Primary completionSep 2014
- Study completionSep 2014
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Skin DiseasesStudies of the same condition, open and under way.
- More trials run by University of ZurichThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Zurich
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Guenther Hofbauer, Prof MD, Principal investigator, University Hospital Zurich, Department of Dermatology
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01969422
- Sponsor's protocol ID
- 2013-0340
- Status last verified
- Dec 2014
- First submitted
- 10 Oct 2013
- Last updated
- 3 Dec 2014
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 3 Dec 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Online Question-answering and Conventional Consultation With a Dermatologist
- ClinicalTrials.gov ID
- NCT01969422
- Acronym / sponsor ID
- 2013-0340
- Conditions
- Skin Diseases
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- University of ZurichUniversity, hospital or other
- Study start
- Nov 2013
- Primary completion
- Sep 2014 (actual)
- Study completion
- Sep 2014 (actual)
- First posted
- 25 Oct 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Comparison of online question-answering system and conventional consultation for dermatological questions:
- same diagnosis?
- same information, which had been collected?
- same recommendations about treatment?
- what were the relevant differences of the two?
Detailed description
mainly, ICD codes and dermatological diagnosis codes according to the AAD will be used.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| observation group | – | Procedure: observationobservation |
Who may qualify
- Ages
- 1 year and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- persons with a question on skin disease
Key inclusion criteria (1 listed)
- a conventional dermatological consultation after a question in the online question-answering system.
Key exclusion criteria (1 listed)
- -power of veto after information of patient
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| observationintervention is the contact with online question answering serice ad subseudd | Procedure or surgery | observation group |
Primary outcome
Correlation of online and clinical diagnosis by Spearman's Rho
Time frame: physical consultation date
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Dec 2014.
Related trials for Skin Diseases
Not yet recruitingPhase 2
Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)
Moderate to Severe Psoriatic Arthritis
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingPhase 1
IL-17 Blockade to Decrease irAEs (REPLAY)
Metastatic Melanoma
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Guenther Hofbauer, Prof MD principal investigator
University Hospital Zurich, Department of Dermatology
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Skin Diseases, run by University of Zurich at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Dec 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Correlation of online and clinical diagnosis by Spearman's Rho (time frame: physical consultation date). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2014.